Study guide

3.2 Ventilation-Perfusion Relationships, Shunt, and Gas Exchange

EDAIC Part I European Diploma in Anaesthesiology and Intensive Care

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: The EDAIC Part I Examination

1.1 EDAIC Part I Exam Format, Scoring and Multiple True/False Strategy

2 Chapter 2: Anatomy for Anaesthesia and Intensive Care

2.1 Functional Anatomy of the Upper Airway, Larynx, and Tracheobronchial Tree 2.2 Neuraxial Anatomy: Spine, Spinal Cord, Meninges, and Spaces 2.3 Vascular Anatomy for Central and Peripheral Cannulation 2.4 Peripheral Nerve Plexuses and Autonomic Nervous System Pathways 2.5 Thoracic Anatomy: Chest Wall, Intercostal Spaces, Pleura, Mediastinum and Heart

3 Chapter 3: Respiratory and Cardiovascular Physiology

3.1 Respiratory Mechanics, Lung Volumes, and Work of Breathing 3.2 Ventilation-Perfusion Relationships, Shunt, and Gas Exchange 3.3 Control of Breathing, Hypoxia, Altitude and Hyperbaric Physiology 3.4 Cardiac Cycle, Electrophysiology, and Ventricular Function 3.5 Vascular Resistance, Microcirculation, and Systemic Hemodynamics

4 Chapter 4: Neurophysiology, Renal, Hepatic and Acid-Base Physiology

4.1 Cerebral Blood Flow, Intracranial Pressure, and CSF Dynamics 4.2 Renal Physiology, Glomerular Filtration, and Tubular Transport 4.3 Hepatic Blood Flow, Metabolism, and Clearance 4.4 Acid-Base Regulation, Buffering Systems, and Stewart Approach

5 Chapter 5: Endocrine and Haematological Physiology

5.1 Endocrine Physiology and the Neuroendocrine Stress Response 5.2 Haemostasis Physiology, Coagulation Testing and Inherited Bleeding Disorders

6 Chapter 6: Special Patient Physiology: Maternal, Paediatric and Geriatric

6.1 Maternal Physiological Adaptations to Pregnancy and Uteroplacental Flow 6.2 Neonatal and Paediatric Physiological Differences 6.3 Physiological Changes of Ageing and Thermoregulation

7 Chapter 7: General Pharmacological Principles and Inhalational Anaesthetics

7.1 Pharmacokinetic Principles, Compartmental Models, and Clearance 7.2 Pharmacodynamic Mechanisms, Receptor Theory, and Drug Interactions 7.3 Physical Properties, Uptake, and Distribution of Volatile Anaesthetics 7.4 Minimum Alveolar Concentration (MAC), Organ Effects, and Toxicity

8 Chapter 8: Intravenous Agents, Neuromuscular Blockade and Analgesics

8.1 Intravenous Induction Agents: Propofol, Etomidate, Ketamine, and Barbiturates 8.2 Neuromuscular Blocking Agents: Depolarizing and Non-Depolarizing Drugs 8.3 Neuromuscular Monitoring and Reversal: Anticholinesterases and Sugammadex 8.4 Opioid Pharmacology, Receptors, and Non-Opioid Analgesic Agents

9 Chapter 9: Cardiovascular Drugs, Autonomic Pharmacology and Local Anaesthetics

9.1 Inotropes, Vasopressors, and Inodilators in Perioperative Care 9.2 Antiarrhythmic, Antihypertensive, and Beta-Adrenergic Antagonist Drugs 9.3 Local Anaesthetic Pharmacology, Toxicity (LAST), and Lipid Emulsion Therapy

10 Chapter 10: Haematological and Internal Medicine Pharmacology

10.1 Anticoagulant, Antiplatelet and Haemostatic Drugs and Their Reversal 10.2 Internal Medicine Drugs: Endocrine, Respiratory, Psychiatric and Antiepileptic Agents and Their Anaesthetic Interactions

11 Chapter 11: Physics, Clinical Measurement and Medical Equipment

11.1 Physical Gas Laws, Fluid Dynamics, and Resistance Principles 11.2 Anaesthetic Machines, Gas Supply Pipelines, Cylinders, and Safety Mechanisms 11.3 Breathing Systems, Vaporizer Mechanics, and Scavenging Systems 11.4 Invasive and Non-Invasive Hemodynamic and Respiratory Monitoring

12 Chapter 12: Electrical Safety, Temperature, Humidity and Gas Analysis

12.1 Electricity, Electrical Safety, Diathermy, Defibrillation, Implanted Devices and Fire 12.2 Temperature Measurement, Humidity, Gas Analysis and SI Units

13 Chapter 13: Biostatistics, Clinical Trials and Evidence Appraisal

13.1 Descriptive Statistics, Distributions, and Parametric vs Non-Parametric Tests 13.2 Hypothesis Testing, Power, Type I/II Errors, and Confidence Intervals 13.3 Clinical Study Designs, Bias, and Diagnostic Test Performance (Sensitivity, Specificity, ROC)

14 Chapter 14: General Anaesthesia, Preoperative Evaluation and Airway Management

14.1 Preoperative Risk Assessment, Cardiovascular Risk Indices, and Fasting Guidelines 14.2 The Difficult Airway: Assessment, Algorithms, and Rescue Oxygenation 14.3 Intraoperative Fluid Therapy, Goal-Directed Hemodynamics, and Blood Conservation 14.4 Post-Anaesthesia Care Unit (PACU) Management, Emergence, and Postoperative Nausea/Vomiting

15 Chapter 15: Coexisting Disease and Preoperative Investigations

15.1 Interpreting Investigations: ECG, Chest Radiograph, Lung Function and Blood Tests 15.2 Coexisting Disease I: Asthma, COPD, Obstructive Sleep Apnoea, Obesity, Liver and Renal Disease 15.3 Endocrine Disease and Emergencies: Diabetes, DKA and HHS, Thyroid, Adrenal, Phaeochromocytoma and Carcinoid 15.4 Coexisting Disease II: Neuromuscular and Neurological Disease

16 Chapter 16: Subspecialty Anaesthesia: Cardiothoracic, Vascular and Neuroanaesthesia

16.1 Anaesthesia for Cardiac Surgery and Cardiopulmonary Bypass Management 16.2 Thoracic Anaesthesia, One-Lung Ventilation, and Major Vascular Surgery 16.3 Neuroanaesthesia: Craniotomy, Sitting Position, and Traumatic Brain Injury

17 Chapter 17: Obstetric, Paediatric and Ambulatory Anaesthesia

17.1 Obstetric Analgesia and Anaesthesia: Labour, Caesarean Delivery, and High-Risk Conditions 17.2 Paediatric Anaesthesia: Induction, Airway Management, and Emergencies 17.3 Ambulatory Day-Surgery Selection, Premedication, and Elderly Patient Anaesthesia

18 Chapter 18: Anaesthetic Complications and Specialty Settings

18.1 Anaesthetic Complications: Accidental Awareness, Aspiration, Positioning Injuries, Visual Loss and Dental Damage 18.2 Anaesthesia for ENT and Laser Airway Surgery, Ophthalmic Surgery, and Laparoscopic and Robotic Surgery

19 Chapter 19: Regional Anaesthesia and Acute/Chronic Pain Management

19.1 Neuraxial Techniques: Spinal, Epidural, and Caudal Anaesthesia 19.2 Upper and Lower Limb Peripheral Nerve and Fascial Plane Blocks 19.3 Multimodal Acute Postoperative Pain Management and ERAS Pathways 19.4 Chronic and Neuropathic Pain Syndromes and Interventional Management 19.5 Palliative Symptom Control, Psychological Aspects of Pain and Multidisciplinary Pain Management

20 Chapter 20: Intensive Care Medicine: Ventilation, Shock and Organ Support

20.1 Acute Respiratory Distress Syndrome (ARDS) and Mechanical Ventilation Strategies 20.2 Sepsis-3 Definitions, Septic Shock, and Hemodynamic Resuscitation 20.3 Acute Kidney Injury, Indications for Dialysis, and Continuous Renal Replacement Therapy 20.4 ICU Sedation, Delirium, Weaning, and Brain Death Determination

21 Chapter 21: Intensive Care Medicine: Admission, Nutrition, Infection and Electrolytes

21.1 ICU Admission, Severity Scoring, Nutrition and Routine Prophylaxis 21.2 Antimicrobial Therapy, Stewardship and ICU-Acquired Infections 21.3 Electrolyte Disorders: Sodium, Potassium, Calcium, Magnesium and Phosphate

22 Chapter 22: Intensive Care and Emergency Medicine: Neurocritical Care, Poisoning and Cardiorespiratory Emergencies

22.1 Neurocritical Care: Subarachnoid Haemorrhage, Stroke, Status Epilepticus and Acute Neuromuscular Failure 22.2 Acute Poisoning: Toxidromes, Decontamination and Specific Antidotes 22.3 Acute Cardiorespiratory Emergencies: Pulmonary Embolism, Acute Severe Asthma and COPD, Non-Invasive Support and Acute Heart Failure

23 Chapter 23: Resuscitation, Perioperative Emergencies and Professional Ethics

23.1 Advanced Life Support (ALS) Guidelines and Perioperative Cardiac Arrest 23.2 Perioperative Crises: Malignant Hyperthermia and Severe Anaphylaxis 23.3 Major Trauma, Hemorrhagic Shock, and Massive Transfusion Protocols 23.4 Professional Ethics, Informed Consent, Patient Safety, and Helsinki Declaration

24 Chapter 24: Newborn, Paediatric and Obstetric Emergencies

24.1 Newborn Life Support and Paediatric Life Support 24.2 Obstetric Emergencies: Maternal Collapse, Amniotic Fluid Embolism, Uterine Inversion and Resuscitative Hysterotomy

25 Chapter 25: Burns, Environmental Emergencies and Patient Transport

25.1 Burns, Inhalation Injury, Drowning, Hypothermia, Heat Illness and Decompression Illness 25.2 Prehospital Care and Intra- and Inter-Hospital Transport of the Critically Ill

3.2 Ventilation-Perfusion Relationships, Shunt, and Gas Exchange

Key Takeaways Explain This Topic AI

West zones explain gravitational perfusion heterogeneity via interactions between pulmonary arterial ( P a P_a P a ​ ), alveolar ( P A P_A P A ​ ), and venous ( P v P_v P v ​ ) pressures: Zone 1 ( P A > P a > P v P_A > P_a > P_v P A ​ > P a ​ > P v ​ ) represents alveolar dead space; Zone 2 ( P a > P A > P v P_a > P_A > P_v P a ​ > P A ​ > P v ​ ) functions as a Starling resistor/waterfall; and Zone 3 ( P a > P v > P A P_a > P_v > P_A P a ​ > P v ​ > P A ​ ) has continuous perfusion driven by P a − P v P_a - P_v P a ​ − P v ​ .

The global normal ventilation-perfusion ratio is ≈ 0.8 \approx 0.8 ≈ 0.8 (ventilation ≈ 4 L/min \approx 4\text{ L/min} ≈ 4 L/min , cardiac output ≈ 5 L/min \approx 5\text{ L/min} ≈ 5 L/min ); both ventilation and perfusion increase down the vertical lung, but perfusion increases more steeply, producing an apex V / Q ≈ 3.3 V/Q \approx 3.3 V / Q ≈ 3.3 and a base V / Q ≈ 0.63 V/Q \approx 0.63 V / Q ≈ 0.63 .

Physiological dead space is quantified by the Bohr-Enghoff equation ( V D V T = P a CO 2 − P E ˉ CO 2 P a CO 2 \frac{V_D}{V_T} = \frac{P_a\text{CO}_2 - P_{\bar{E}}\text{CO}_2}{P_a\text{CO}_2} V T ​ V D ​ ​ = P a ​ CO 2 ​ P a ​ CO 2 ​ − P E ˉ ​ CO 2 ​ ​ , normal 0.20–0.35); true intrapulmonary shunt (governed by the Berggren equation Q s Q t = C c ′ O 2 − C a O 2 C c ′ O 2 − C v ˉ O 2 \frac{Q_s}{Q_t} = \frac{C_c'\text{O}_2 - C_a\text{O}_2}{C_c'\text{O}_2 - C_{\bar{v}}\text{O}_2} Q t ​ Q s ​ ​ = C c ′ ​ O 2 ​ − C v ˉ ​ O 2 ​ C c ′ ​ O 2 ​ − C a ​ O 2 ​ ​ ) is refractory to supplemental oxygen, distinguishing it from low V / Q V/Q V / Q units.

Hypoxic Pulmonary Vasoconstriction (HPV) constricts precapillary arterioles in response to alveolar hypoxia ( P A O 2 < 100 mmHg P_A\text{O}_2 < 100\text{ mmHg} P A ​ O 2 ​ < 100 mmHg ) to redirect flow toward ventilated units; it is dose-dependently blunted by volatile anaesthetics ( > 1 MAC >1\text{ MAC} > 1 MAC ), intravenous vasodilators, and hypocapnic alkalosis.

Last updated: October 2026

3.2 Ventilation-Perfusion Relationships, Shunt, and Gas Exchange

Efficient pulmonary gas exchange depends upon the matching of alveolar ventilation ( V ˙ \dot{V} V ˙ ) to pulmonary capillary blood flow ( Q ˙ \dot{Q} Q ˙ ​ ). This section analyzes the gravitational distributions of ventilation and perfusion, the West zones, mathematical models of gas exchange, hypoxic pulmonary vasoconstriction, and blood gas transport mechanisms.

1. West Zones of the Lung

The pulmonary circulation is a high-flow, low-resistance, highly compliant vascular bed. Mean pulmonary arterial pressure ( M P A P MPAP MP A P ) is normally only ≈ 15 mmHg \approx 15\text{ mmHg} ≈ 15 mmHg ( 20 cmH 2 O 20\text{ cmH}_2\text{O} 20 cmH 2 ​ O ). In an erect adult, the vertical height of the lung spans approximately 30 cm 30\text{ cm} 30 cm ; the pulmonary artery enters the hilum at mid-height, meaning hydrostatic pressure drops by ≈ 15 cmH 2 O \approx 15\text{ cmH}_2\text{O} ≈ 15 cmH 2 ​ O at the lung apex and rises by ≈ 15 cmH 2 O \approx 15\text{ cmH}_2\text{O} ≈ 15 cmH 2 ​ O at the base.

John B. West characterized three physiological zones (with an additional pathological Zone 4) based on the relative relationships between pulmonary arterial pressure ( P a P_a P a ​ ), alveolar gas pressure ( P A P_A P A ​ ), and pulmonary venous pressure ( P v P_v P v ​ ): TOP OF LUNG (Apex)

  • ==================
  • [ ZONE 1: PA > Pa > Pv ] --> Alveolar Dead Space (No perfusion)
  • ----------------------
  • [ ZONE 2: Pa > PA > Pv ] --> Waterfall / Starling Resistor
  • ----------------------
  • [ ZONE 3: Pa > Pv > PA ] --> Continuous Flow (Pa - Pv drives flow)
  • ==================
  • [ ZONE 4: Pa > Pis > Pv > PA ] --> Interstitial compression (Edema/low FRC)
  • BASE OF LUNG
  • Detailed Zonal Characteristics

Zone Pressure Relationship Determinant of Perfusion Physiological Status / Clinical Correlation

Zone 1 P A > P a > P v P_A > P_a > P_v P A ​ > P a ​ > P v ​ No flow (capillaries squashed by alveolar pressure) Absent under normal spontaneous breathing. Created iatrogenically by positive pressure ventilation, high PEEP, or severe hypovolemia/shock. Represents alveolar dead space .

Zone 2 P a > P A > P v P_a > P_A > P_v P a ​ > P A ​ > P v ​ P a − P A P_a - P_A P a ​ − P A ​ ("Waterfall" or Starling resistor effect) Arterial pressure exceeds alveolar pressure, opening the arterial end, but alveolar pressure exceeds venous pressure, compressing the venular end. Flow is independent of downstream venous pressure.

Zone 3 P a > P v > P A P_a > P_v > P_A P a ​ > P v ​ > P A ​ P a − P v P_a - P_v P a ​ − P v ​ (Arteriovenous pressure gradient) Capillaries are continuously held open by positive transmural distending pressure. Flow is maximal and governed by the true arteriovenous gradient.

Zone 4 P a > P i s > P v > P A P_a > P_{is} > P_v > P_A P a ​ > P i s ​ > P v ​ > P A ​ P a − P i s P_a - P_{is} P a ​ − P i s ​ (Perivascular interstitial pressure) Present at the extreme lung bases during low lung volumes or pulmonary edema. Fluid accumulation in the bronchovascular interstitial space ( P i s P_{is} P i s ​ ) compresses extra-alveolar vessels, reducing local blood flow.

  • 2. Ventilation-Perfusion ( V / Q V/Q V / Q ) Relationships and Regional Disparities
  • Global vs Regional V / Q V/Q V / Q

Global V / Q V/Q V / Q Ratio: In a resting 70 kg 70\text{ kg} 70 kg adult, total alveolar ventilation ( V ˙ A \dot{V}_A V ˙ A ​ ) is approximately 4.0 L/min 4.0\text{ L/min} 4.0 L/min and pulmonary capillary blood flow (cardiac output, Q ˙ \dot{Q} Q ˙ ​ ) is approximately 5.0 L/min 5.0\text{ L/min} 5.0 L/min . The overall resting V / Q V/Q V / Q ratio is ≈ 0.8 \approx 0.8 ≈ 0.8 .

Gravitational Gradients: Gravity exerts differential hydrostatic forces on both air and blood in the vertical lung:

Ventilation: Due to the weight of the lung, intrapleural pressure is more negative at the apex ( ≈ − 10 cmH 2 O \approx -10\text{ cmH}_2\text{O} ≈ − 10 cmH 2 ​ O ) than at the base ( ≈ − 2.5 cmH 2 O \approx -2.5\text{ cmH}_2\text{O} ≈ − 2.5 cmH 2 ​ O ). Apical alveoli are subjected to a higher transpulmonary distending pressure, making them large, distended, and situated near the flat top of their compliance curve at FRC. Basal alveoli are smaller at FRC, sitting on the steep, compliant portion of the curve. Consequently, alveolar ventilation increases from apex to base .

Perfusion: Hydrostatic fluid pressure increases down the vertical column. Thus, pulmonary blood flow increases from apex to base .

The Critical Divergence: Blood has a far higher density than gas. Therefore, perfusion increases down the lung much more rapidly than ventilation . Lung Region | Ventilation (V) | Perfusion (Q) | V/Q Ratio | PAO2 | PACO2

  • -----------+-----------------+---------------+-----------+---------------+--------------
  • Apex | Lower | Much Lower | High ~3.3 | 130 mmHg | 28 mmHg
  • | | | (Alv dead)| (17.3 kPa) | (3.7 kPa)
  • -----------+-----------------+---------------+-----------+---------------+--------------
  • Base | Higher | Much Higher | Low ~0.63 | 89 mmHg | 42 mmHg
  • | | | (Shunt-l.)| (11.8 kPa) | (5.6 kPa)
  • 3. Dead Space, Intrapulmonary Shunt, and Core Equations
  • Dead Space ( V / Q = ∞ V/Q = \infty V / Q = ∞ )

Dead space represents ventilation of lung regions that do not participate in gas exchange.

Anatomical Dead Space ( V D , anat V_{D,\text{anat}} V D , anat ​ ): Gas within non-respiratory conducting airways (from mouth/nose down to terminal bronchioles). Quantified clinically by Fowler's single-breath nitrogen washout method ( 100 % O 2 100\%\text{ O}_2 100% O 2 ​ single breath, plotting expired nitrogen against volume). Approximately 2.0 − 2.2 mL/kg 2.0-2.2\text{ mL/kg} 2.0 − 2.2 mL/kg (roughly 150 mL 150\text{ mL} 150 mL in a 70 kg 70\text{ kg} 70 kg adult).

Alveolar Dead Space ( V D , alv V_{D,\text{alv}} V D , alv ​ ): Alveoli that are ventilated but unperfused ( V / Q = ∞ V/Q = \infty V / Q = ∞ ; West Zone 1).

Physiological Dead Space ( V D , phys V_{D,\text{phys}} V D , phys ​ ): The sum of anatomical and alveolar dead space ( V D , phys = V D , anat + V D , alv V_{D,\text{phys}} = V_{D,\text{anat}} + V_{D,\text{alv}} V D , phys ​ = V D , anat ​ + V D , alv ​ ).

The Bohr-Enghoff Equation

The Enghoff modification uses arterial carbon dioxide tension ( P a CO 2 P_a\text{CO}_2 P a ​ CO 2 ​ ) as a surrogate for mean alveolar CO 2 \text{CO}_2 CO 2 ​ tension:

V D V T = P a CO 2 − P E ˉ CO 2 P a CO 2 \frac{V_D}{V_T} = \frac{P_a\text{CO}_2 - P_{\bar{E}}\text{CO}_2}{P_a\text{CO}_2} V T ​ V D ​ ​ = P a ​ CO 2 ​ P a ​ CO 2 ​ − P E ˉ ​ CO 2 ​ ​

Where P E ˉ CO 2 P_{\bar{E}}\text{CO}_2 P E ˉ ​ CO 2 ​ is the partial pressure of CO 2 \text{CO}_2 CO 2 ​ in mixed expired gas collected over several respiratory cycles.

Normal Value: 0.20 − 0.35 0.20-0.35 0.20 − 0.35 in awake, spontaneously breathing adults.

Anaesthesia and Ventilation: Increases to 0.40 − 0.50 0.40-0.50 0.40 − 0.50 during general anaesthesia with positive pressure ventilation.

Causes of Increased Dead Space: High PEEP, alveolar overdistension, pulmonary embolism, hypovolemia/hypotension, erect posture, anticholinergic bronchodilators, and mechanical apparatus dead space (heat-and-moisture exchangers, catheter mounts, bacterial filters).

Intrapulmonary Shunt ( V / Q = 0 V/Q = 0 V / Q = 0 )

Shunt occurs when deoxygenated venous blood passes from the right to the left side of the circulation without participating in gas exchange.

Anatomical Shunt: Normal physiological venous admixture ( ≈ 2 − 5 % \approx 2-5\% ≈ 2 − 5% of total cardiac output) bypassing alveolar capillaries:

Thebesian veins (venae cordis minimae) draining directly into the left atrium and left ventricle.

Bronchial veins draining deoxygenated blood into the pulmonary veins.

Pathological Shunt: Perfusion of unventilated alveolar units ( V / Q = 0 V/Q = 0 V / Q = 0 ):

  • Atelectasis (compression or absorption)
  • Alveolar consolidation (pneumonia, dense pulmonary edema, severe ARDS)

Intracardiac right-to-left shunts (e.g. Eisenmenger syndrome, Tetralogy of Fallot, probe-patent foramen ovale with high right-sided pressures)

The Berggren Shunt Equation

Derived from the conservation of mass for oxygen:

Q s Q t = C c ′ O 2 − C a O 2 C c ′ O 2 − C v ˉ O 2 \frac{Q_s}{Q_t} = \frac{C_c'\text{O}_2 - C_a\text{O}_2}{C_c'\text{O}_2 - C_{\bar{v}}\text{O}_2} Q t ​ Q s ​ ​ = C c ′ ​ O 2 ​ − C v ˉ ​ O 2 ​ C c ′ ​ O 2 ​ − C a ​ O 2 ​ ​

Where:

Q s / Q t Q_s / Q_t Q s ​ / Q t ​ is the fraction of total cardiac output that is shunted.

C c ′ O 2 C_c'\text{O}_2 C c ′ ​ O 2 ​ is pulmonary end-capillary oxygen content (calculated assuming capillary P O 2 P\text{O}_2 P O 2 ​ equals alveolar P A O 2 P_A\text{O}_2 P A ​ O 2 ​ ).

C a O 2 C_a\text{O}_2 C a ​ O 2 ​ is systemic arterial oxygen content.

C v ˉ O 2 C_{\bar{v}}\text{O}_2 C v ˉ ​ O 2 ​ is mixed venous oxygen content (measured from a pulmonary artery catheter).

The Cardinal Clinical Distinction between Shunt and Low V / Q V/Q V / Q :

Low V / Q V/Q V / Q Mismatch ( 0 < V / Q < 1 0 < V/Q < 1 0 < V / Q < 1 ): Responds readily to supplemental oxygen. Administering higher F i O 2 F_i\text{O}_2 F i ​ O 2 ​ increases end-capillary oxygen content in poorly ventilated units, correcting arterial hypoxemia.

True Shunt ( V / Q = 0 V/Q = 0 V / Q = 0 ): Refractory to 100 % O 2 100\%\text{ O}_2 100% O 2 ​ . Because shunted blood never contacts alveolar gas, high F i O 2 F_i\text{O}_2 F i ​ O 2 ​ cannot oxygenate it. Blood traversing normal alveoli is already fully saturated ( ≈ 100 % \approx 100\% ≈ 100% ); the tiny volume of additional dissolved oxygen ( 0.003 mL O 2 / dL / mmHg 0.003\text{ mL } \text{O}_2/\text{dL}/\text{mmHg} 0.003 mL O 2 ​ / dL / mmHg ) cannot offset the desaturating impact of the unoxygenated shunted blood.

The Alveolar Gas Equation

Calculates ideal alveolar oxygen tension ( P A O 2 P_A\text{O}_2 P A ​ O 2 ​ ):

P A O 2 = F i O 2 ⋅ ( P atm − P H 2 O ) − P a CO 2 R P_A\text{O}_2 = F_i\text{O}_2 \cdot (P_{\text{atm}} - P_{\text{H}_2\text{O}}) - \frac{P_a\text{CO}_2}{R} P A ​ O 2 ​ = F i ​ O 2 ​ ⋅ ( P atm ​ − P H 2 ​ O ​ ) − R P a ​ CO 2 ​ ​

Where:

P atm P_{\text{atm}} P atm ​ is barometric pressure ( 760 mmHg 760\text{ mmHg} 760 mmHg or 101.3 kPa 101.3\text{ kPa} 101.3 kPa at sea level).

P H 2 O P_{\text{H}_2\text{O}} P H 2 ​ O ​ is saturated water vapor pressure at body temperature ( 37 ∘ C 37^\circ\text{C} 3 7 ∘ C ), which is 47 mmHg 47\text{ mmHg} 47 mmHg ( 6.3 kPa 6.3\text{ kPa} 6.3 kPa ).

R R R is the respiratory quotient (moles CO 2 \text{CO}_2 CO 2 ​ produced / moles O 2 \text{O}_2 O 2 ​ consumed ≈ 0.8 \approx 0.8 ≈ 0.8 under normal resting metabolic diets).

Sea-Level Room Air Example ( F i O 2 = 0.21 F_i\text{O}_2 = 0.21 F i ​ O 2 ​ = 0.21 , P a CO 2 = 40 mmHg P_a\text{CO}_2 = 40\text{ mmHg} P a ​ CO 2 ​ = 40 mmHg ): P A O 2 = 0.21 × ( 760 − 47 ) − 40 0.8 = 0.21 × 713 − 50 = 149.7 − 50 ≈ 100 mmHg (13.3 kPa) P_A\text{O}_2 = 0.21 \times (760 - 47) - \frac{40}{0.8} = 0.21 \times 713 - 50 = 149.7 - 50 \approx 100\text{ mmHg} \text{ (13.3 kPa)} P A ​ O 2 ​ = 0.21 × ( 760 − 47 ) − 0.8 40 ​ = 0.21 × 713 − 50 = 149.7 − 50 ≈ 100 mmHg (13.3 kPa)

Alveolar-arterial Oxygen Gradient ( A − a gradient A-a\text{ gradient} A − a gradient ):

A − a gradient = P A O 2 − P a O 2 A-a\text{ gradient} = P_A\text{O}_2 - P_a\text{O}_2 A − a gradient = P A ​ O 2 ​ − P a ​ O 2 ​ .

Normal Value: < 10 − 15 mmHg <10-15\text{ mmHg} < 10 − 15 mmHg on room air in young adults. Expected normal increases with age: Expected A − a ≈ Age 4 + 4 \text{Expected } A-a \approx \frac{\text{Age}}{4} + 4 Expected A − a ≈ 4 Age ​ + 4 .

Elevated in V / Q V/Q V / Q mismatch, shunt, and diffusion impairment; normal in pure hypoventilation or high-altitude hypoxemia.

  • 4. Hypoxic Pulmonary Vasoconstriction (HPV)
  • Physiological Mechanism

Hypoxic Pulmonary Vasoconstriction is an intrinsic, protective homeostatic reflex unique to the pulmonary vasculature. In contrast to systemic arterioles (which dilate in response to hypoxia), pulmonary precapillary arterioles constrict when exposed to low oxygen tensions.

Primary Sensor: HPV responds predominantly to alveolar oxygen tension ( P A O 2 P_A\text{O}_2 P A ​ O 2 ​ ) , not mixed venous oxygen tension ( P v ˉ O 2 P_{\bar{v}}\text{O}_2 P v ˉ ​ O 2 ​ ).

Trigger Threshold: Vasoconstriction begins when P A O 2 P_A\text{O}_2 P A ​ O 2 ​ drops below 100 mmHg 100\text{ mmHg} 100 mmHg ( 13.3 kPa 13.3\text{ kPa} 13.3 kPa ) and reaches maximal intensity when P A O 2 < 50 mmHg P_A\text{O}_2 < 50\text{ mmHg} P A ​ O 2 ​ < 50 mmHg ( 6.7 kPa 6.7\text{ kPa} 6.7 kPa ).

Cellular Pathway: Hypoxia inhibits voltage-gated potassium channels ( K v K_v K v ​ ) in pulmonary arterial smooth muscle cells. The resulting cell depolarization opens L-type voltage-gated calcium channels, promoting intracellular calcium influx and phosphorylation of myosin light chains, driving sustained vasoconstriction.

Functional Role: Diverts blood away from hypoxic, poorly ventilated alveoli toward well-ventilated regions, thereby minimizing V / Q V/Q V / Q mismatch and intrapulmonary shunt.

Factors Inhibiting (Blunting) HPV

Mechanism / Class Specific Agents or Conditions Clinical Consequence

Inhalational Anaesthetics Isoflurane, Sevoflurane, Desflurane Dose-dependent inhibition; clinically pronounced at > 1.0 MAC >1.0\text{ MAC} > 1.0 MAC . Blunts HPV during one-lung ventilation (OLV) in thoracic surgery, exacerbating hypoxemia.

Intravenous Vasodilators Sodium nitroprusside, nitroglycerin, hydralazine, calcium channel blockers, PDE-5 inhibitors Direct smooth muscle relaxation overrides HPV, causing pulmonary vasodilation in non-ventilated lung units and worsening shunt.

Ventilatory / Acid-Base Hypocapnia ( P CO 2 < 35 mmHg P\text{CO}_2 < 35\text{ mmHg} P CO 2 ​ < 35 mmHg ) and Alkalosis Causes pulmonary vasodilation, blunting HPV. (Conversely, hypercapnia and acidosis augment HPV).

Hemodynamic Factors High left atrial pressure (fluid overload, mitral stenosis), high cardiac output Mechanically distends pulmonary capillaries, overriding vasoconstriction.

Anaesthetic Maintenance Pearl: Intravenous anaesthetic agents (such as propofol, ketamine, and dexmedetomidine ) do not inhibit HPV. For this reason, Total Intravenous Anaesthesia (TIVA) with propofol is widely considered the anaesthetic technique of choice during one-lung ventilation in thoracic surgery to preserve maximal HPV in the non-dependent collapsed lung.

  • 5. Oxygen and Carbon Dioxide Transport Dynamics
  • The Oxygen Cascade

Oxygen cascades down a progressive partial pressure gradient from the atmosphere to the cellular mitochondria: 1. Ambient Dry Air: 160 mmHg (21.3 kPa) [0.21 x 760]

  • |
  • 2. Tracheal Gas (Humidified): 150 mmHg (20.0 kPa) [0.21 x (760 - 47)]
  • |
  • 3. Alveolar Gas: 100 mmHg (13.3 kPa) [Alveolar Gas Equation]
  • |
  • 4. Systemic Arterial Blood: 95 mmHg (12.6 kPa) [Anatomical shunt & V/Q]
  • |
  • 5. Capillary Blood: 40-50 mmHg (5.3-6.7 kPa)
  • |
  • 6. Intracellular Cytosol: 10-30 mmHg (1.3-4.0 kPa)
  • |
  • 7. Mitochondria: 1-10 mmHg (0.13-1.3 kPa) [Critical PO2 ~0.1 kPa]
  • Oxyhaemoglobin Dissociation Curve

Haemoglobin is a tetramer containing four heme groups, each binding one molecule of O 2 \text{O}_2 O 2 ​ . The sigmoidal contour of the curve reflects positive cooperativity : binding of an oxygen molecule to one heme subunit alters the quaternary protein conformation, progressively increasing the oxygen affinity of remaining vacant subunits. % Hb Saturation (SaO2)

  • 100 ^ /------------------
  • | / LEFT SHIFT (Increased affinity: pH up, Temp/DPG/CO2 down)
  • 75 | / |
  • | / | NORMAL (P50 = 26.7 mmHg)
  • 50 |-----------*----+---
  • | / | | RIGHT SHIFT (Decreased affinity: Bohr effect, CADET)
  • 25 | / | |
  • | / | |
  • 0 +-----+-----+----+------------------> PO2 (mmHg)
  • 20 26.7 40

P 50 P_{50} P 50 ​ : The partial pressure of oxygen at which haemoglobin is 50 % 50\% 50% saturated under standard physiological conditions ( p H = 7.40 pH = 7.40 p H = 7.40 , P CO 2 = 40 mmHg P\text{CO}_2 = 40\text{ mmHg} P CO 2 ​ = 40 mmHg , T = 37 ∘ C T = 37^\circ\text{C} T = 3 7 ∘ C ): 26.7 mmHg 26.7\text{ mmHg} 26.7 mmHg ( 3.6 kPa 3.6\text{ kPa} 3.6 kPa ).

Right Shift (Decreased O 2 \text{O}_2 O 2 ​ Affinity → \rightarrow → Promotes Tissue O 2 \text{O}_2 O 2 ​ Unloading): Higher P O 2 P\text{O}_2 P O 2 ​ needed to achieve 50 % 50\% 50% saturation ( P 50 > 26.7 mmHg P_{50} > 26.7\text{ mmHg} P 50 ​ > 26.7 mmHg ).

  • Increased H + \text{H}^+ H + concentration (acidosis / lower p H pH p H ; the Bohr Effect )
  • Increased P CO 2 P\text{CO}_2 P CO 2 ​ (hypercapnia)
  • Increased temperature (pyrexia, hyperthermia)
  • Increased 2,3-diphosphoglycerate (2,3-DPG; chronic hypoxemia, anemia, high altitude)

Mnemonic: CADET face Right : C O 2 _2 2 ​ , A cid, D PG, E xercise, T emperature.

Left Shift (Increased O 2 \text{O}_2 O 2 ​ Affinity → \rightarrow → Impairs Tissue O 2 \text{O}_2 O 2 ​ Unloading): Lower P O 2 P\text{O}_2 P O 2 ​ achieves 50 % 50\% 50% saturation ( P 50 < 26.7 mmHg P_{50} < 26.7\text{ mmHg} P 50 ​ < 26.7 mmHg ).

  • Decreased H + \text{H}^+ H + (alkalosis / higher p H pH p H )
  • Decreased P CO 2 P\text{CO}_2 P CO 2 ​ (hypocapnia)
  • Decreased temperature (hypothermia)
  • Decreased 2,3-DPG (massively transfused stored banked blood; 2,3-DPG depletes after 1-2 weeks of storage)
  • Carboxyhaemoglobin (COHb), Methaemoglobin (MetHb), Foetal haemoglobin (HbF)
  • Carbon Dioxide Transport and the Haldane Effect

Carbon dioxide is transported in blood in three forms:

Bicarbonate (~70%): Produced inside erythrocytes. Carbonic anhydrase converts CO 2 + H 2 O ⇌ H 2 CO 3 ⇌ H + + HCO 3 − \text{CO}_2 + \text{H}_2\text{O} \rightleftharpoons \text{H}_2\text{CO}_3 \rightleftharpoons \text{H}^+ + \text{HCO}_3^- CO 2 ​ + H 2 ​ O ⇌ H 2 ​ CO 3 ​ ⇌ H + + HCO 3 − ​ . The generated HCO 3 − \text{HCO}_3^- HCO 3 − ​ exits the RBC into plasma via the anion exchanger 1 (AE1) in exchange for chloride entering the cell ( Chloride Shift or Hamburger Phenomenon ).

Carbamino Compounds ( ≈ 23 % \approx 23\% ≈ 23% ): CO 2 \text{CO}_2 CO 2 ​ binds directly to uncharged terminal amino groups of globin chains (predominantly carbamino-haemoglobin). Deoxygenated haemoglobin binds twice as much CO 2 \text{CO}_2 CO 2 ​ as oxyhaemoglobin.

Dissolved in Plasma ( ≈ 7 % \approx 7\% ≈ 7% ): CO 2 \text{CO}_2 CO 2 ​ is ≈ 24 times \approx 24\text{ times} ≈ 24 times more soluble in plasma than O 2 \text{O}_2 O 2 ​ (solubility coefficient α = 0.03 mmol/L/mmHg \alpha = 0.03\text{ mmol/L/mmHg} α = 0.03 mmol/L/mmHg or 0.067 mL/dL/mmHg 0.067\text{ mL/dL/mmHg} 0.067 mL/dL/mmHg ).

The Haldane Effect: Deoxygenation of blood increases its capacity to carry carbon dioxide, while oxygenation promotes CO 2 \text{CO}_2 CO 2 ​ unloading. Oxyhaemoglobin is a stronger acid than deoxygenated haemoglobin; when oxygen binds heme in the pulmonary capillaries, protons ( H + \text{H}^+ H + ) are released from globin. These protons titrate bicarbonate back into carbonic acid, generating molecular CO 2 \text{CO}_2 CO 2 ​ that diffuses out into the alveolus. In systemic tissues, oxygen unloading allows deoxyhaemoglobin to buffer H + \text{H}^+ H + and bind carbamino compounds, maximizing CO 2 \text{CO}_2 CO 2 ​ extraction.